Kansas HB2353 mandates written notices to patients about potential legal and health risks when prescribed abortion-inducing drugs.
Kansas HB2353 requires physicians and healthcare providers to give patients a written notice about the potential legal and health risks associated with abortion-inducing drugs. The notice informs patients that they and their families may hold the manufacturer, distributor, and healthcare provider financially accountable for any adverse outcomes, including death, injury, complications, or failure of the medication. It also emphasizes the patient's right to disclose their use of abortion-inducing drugs during emergency care without facing penalties.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.